2023 annual financial data
NewAmsterdam Pharma 2023 Net margin
Direct answer
Net margin was -1,255.76%.
Operating income was -182,967,000 EUR and net income was -176,937,000 EUR.
Operating cash flow was -141,218,000 EUR.
Get free NewAmsterdam Pharma email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 14,090,000 EUR
- Operating income
- -182,967,000 EUR
- Net income
- -176,937,000 EUR
- Operating cash flow
- -141,218,000 EUR